DocCheck AG (ETR:AJ91)
Germany · Delayed Price · Currency is EUR 10.50
0.00 (0.00%)
Oct 26, 2026, 5:35 PM CET
DocCheck AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 56.65 | 55.32 | 53.79 | 53.41 | 60.9 | 85.92 |
| 56.65 | 55.32 | 53.79 | 53.41 | 60.9 | 85.92 | |
Revenue Growth | 1.35% | 2.84% | 0.69% | -12.29% | -29.12% | 36.17% |
Cost of Revenue | 43.47 | 40.75 | 41.22 | 40.44 | 43.97 | 61.82 |
Gross Profit | 13.17 | 14.57 | 12.56 | 12.97 | 16.93 | 24.1 |
Selling, General & Admin | 1.32 | 1.32 | 1.3 | - | - | - |
Other Operating Expenses | 2.63 | 3.01 | 2.51 | 4.51 | 5.28 | 5.15 |
Operating Expenses | 6.9 | 7.15 | 6.28 | 9.59 | 8.17 | 7.7 |
Operating Income | 6.27 | 7.42 | 6.29 | 3.39 | 8.76 | 16.4 |
Interest Expense | -0.5 | -0.41 | -0.19 | -0.13 | -1.21 | -0.24 |
Interest & Investment Income | 0.6 | 0.59 | 1.14 | 0.97 | 0.12 | 0.89 |
Currency Exchange Gain (Loss) | 0.02 | 0.02 | 0.02 | 0.05 | 0.12 | 0.08 |
Other Non Operating Income (Expenses) | 0.68 | 0.68 | 0.21 | -0 | 0.25 | 0.09 |
EBT Excluding Unusual Items | 7.07 | 8.29 | 7.46 | 4.28 | 8.05 | 17.22 |
Gain (Loss) on Sale of Investments | 0.02 | 0.02 | 0.08 | 0.06 | 1.27 | 0.05 |
Gain (Loss) on Sale of Assets | 0.01 | 0.01 | 0.01 | 0.04 | 0 | 0.01 |
Pretax Income | 7.12 | 8.34 | 7.56 | 4.38 | 9.32 | 17.29 |
Income Tax Expense | 2.46 | 3.01 | 2.27 | 2.25 | 3.05 | 5.46 |
Earnings From Continuing Operations | 4.66 | 5.33 | 5.28 | 2.13 | 6.27 | 11.82 |
Minority Interest in Earnings | - | - | - | 0.14 | 0.02 | -0.42 |
Net Income | 4.66 | 5.33 | 5.28 | 2.27 | 6.29 | 11.4 |
Net Income to Common | 4.66 | 5.33 | 5.28 | 2.27 | 6.29 | 11.4 |
Net Income Growth | -20.52% | 0.96% | 132.60% | -63.89% | -44.85% | 23.93% |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change | - | - | 0.10% | 0.15% | -0.10% | 0.33% |
EPS (Basic) | 0.92 | 1.05 | 1.04 | 0.45 | 1.25 | 2.27 |
EPS (Diluted) | 0.92 | 1.05 | 1.04 | 0.45 | 1.24 | 2.25 |
EPS Growth | -20.06% | 0.96% | 131.98% | -63.85% | -44.89% | 23.63% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 1.46 | 2.45 | 6.64 | 5.67 | -0.42 | 7.05 |
Free Cash Flow Per Share | 0.29 | 0.48 | 1.31 | 1.12 | -0.08 | 1.39 |
Dividend Per Share | 1.000 | 1.000 | 0.750 | 0.500 | 0.750 | 1.000 |
Dividend Growth | 33.33% | 33.33% | 50.00% | -33.33% | -25.00% | 0% |
Gross Margin | 23.25% | 26.33% | 23.36% | 24.29% | 27.80% | 28.05% |
Operating Margin | 11.07% | 13.41% | 11.69% | 6.34% | 14.39% | 19.08% |
Profit Margin | 8.24% | 9.64% | 9.82% | 4.25% | 10.33% | 13.27% |
Free Cash Flow Margin | 2.58% | 4.43% | 12.35% | 10.62% | -0.68% | 8.21% |
EBITDA | 8.06 | 9.08 | 7.82 | 7.37 | 10.4 | 18.85 |
EBITDA Margin | 14.23% | 16.41% | 14.54% | 13.80% | 17.08% | 21.94% |
D&A For EBITDA | 1.79 | 1.66 | 1.53 | 3.98 | 1.64 | 2.45 |
EBIT | 6.27 | 7.42 | 6.29 | 3.39 | 8.76 | 16.4 |
EBIT Margin | 11.07% | 13.41% | 11.69% | 6.34% | 14.39% | 19.08% |
Effective Tax Rate | 34.52% | 36.07% | 30.09% | 51.42% | 32.73% | 31.60% |